Figure 3 shows the 13C chemical shift differences between
the spectra of 1a-h in (R)- and (S)-DMBA. Under the
(R)- and (S)-DMBA,12 and the preparation included in the
Supporting Information meets with our needs. We were
pleased to observe that (R)- and (S)-DMBA-d13 could easily
dissolve oasomycin A13 (>10 mg/0.5 mL) but disappointed
to see that the NMR signals were very broad in DMBA.
Since aggregation appeared to be the probable cause for the
observed signal broadening, we tested (R)- and (S)-DMBA-
d13 containing 9.1% DMSO-d6 (DMBA/DMSO ) 10:1) and
were delighted to observe sharp, well-resolved signals.14,15
We then examined the capacity to discriminate enantiomers
and found that although the degree of chemical shift
differences decreases with an increase in DMSO content,
(R)- and (S)-DMBA-d13 containing 9.1% DMSO-d6 satis-
factorily met with our needs (Figure 4).
Figure 4. Difference in carbon chemical shifts for C.5 and C.7 of
1e (100 MHz) in DMBA containing DMSO-d6. The x- and y-axes
represent DMSO-d6 content (v/v %) in (R)- or (S)-DMBA and
|∆δR-S| in ppm, respectively.
Figure 3. Difference in carbon chemical shifts of 1a-h (100 MHz)
between (R)- and (S)-DMBA. The x- and y-axes represent carbon
number and δR - δS in ppm, respectively.
To correlate the NMR profile of the C.5-C.10 segment
of oasomycin A (Figure 5) with that of 1a-h, it was
conditions of measurement, a chemical shift difference of
0.010 ppm is reliably detected.9 The 13C chemical shift
differences observed in (R)- and (S)-DMBA are well beyond
this limit for 1a-h. Thus, the absolute configuration of a
given dipropionate motif can be deduced through comparison
of the 13C NMR profile in (R)-DMBA with that in (S)-
DMBA, in reference to the corresponding diastereomer
among 1a-h.
To assess the feasibility and reliability of the NMR
database approach in a chiral solvent, we chose first to use
the C.5-C.10 portion of the desertomycin/oasomycin class
of natural products.10,11 For this purpose, we needed to
develop a practical and scalable synthesis of perdeuterated
Figure 5. Structure of oasomycin A.
(6) A Varian Mercury 400 spectrometer (100 MHz) was used to collect
all data for 1a-h in DMBA, with acetone-d6 as an external reference (δ
29.8) and a lock-signal and with readout of NMR spectra being adjusted to
0.001 ppm/point (sw ) 23980.8, fn ) 524288).
(7) The chemical shift assignments were established via the same
procedure as the one used for oasomycin A. The details are included in the
Supporting Information.
necessary to establish the 13C chemical shift assignment for
the antibiotic in (R)- or (S)-DMBA-d13 containing 9.1%
DMSO-d6. Given the complete chemical shift assignment
(8) In DMBA, the overall profile of 1b and 1f is similar to that of 1d
and 1h, respectively. In DMSO, however, the overall profile of 1b is notably
different from that of 1d. In addition, the difference between 1f and 1h is
more visible in DMSO than in DMBA.
(9) Half-bandwidth was 0.008 ppm in nondeuterated DMBA.
(10) Desertomycins: (a) Bax, A.; Aszalos, A.; Dinya, Z.; Sudo, K. J.
Am. Chem. Soc. 1986, 108, 8056-8063. (b) Dinya, Z.; Sztaricskai, F.;
Horvath, E.; Schaag, J. B. Rapid Commun. Mass Spectrom. 1996, 10, 1439-
1448 and references therein.
(11) Oasomycins: (a) Grabley, S.; Kretzschmar, G.; Mayer, M.; Philipps,
S.; Thiericke, R.; Wink, J.; Zeeck, A. Liebigs Ann. Chem. 1993, 573-579.
(b) Mayer, M.; Thiericke, R. J. Chem. Soc., Perkin Trans. 1 1993, 2525-
2531.
(12) Although perdeuterated phenethylamine is known (Ohhara, T.;
Harada, J.; Ohashi, Y.; Tanaka, I.; Kumazawa, S.; Niimura, N. Acta
Crystallogr. 2000, B56, 245-253.), we prefer the method included in the
Supporting Information in terms of scalability, practicability, and cost.
(13) We thank Dr. Gerhard Kretzschmar for a sample of oasomycin A.
(14) A Varian INOVA 500 spectrometer (125 MHz) at Eisai Research
Institute of Boston was used to record all NMR spectra of oasomycin A in
(R)- and (S)-DMBA-d13, with DMSO-d6 as an internal reference (δ 39.5).
Eight out of 55 carbon signals of oasomycin A are hidden under the solvent
peaks (see the spectrum included in the Supporting Information).
(15) Enantiomeric discrimination of 1e was observed in DMBA contain-
ing 9.1% of the following cosolvents: CD3OD, CDCl3, CD3CN, C5D5N,
(CD3)2CO, and C6D6.
Org. Lett., Vol. 3, No. 14, 2001
2247